Literature DB >> 20121601

Protocol for the examination of specimens from patients with gastrointestinal stromal tumor.

Brian P Rubin1, Charles D Blanke, George D Demetri, Ronald P Dematteo, Christopher D M Fletcher, John R Goldblum, Jerzy Lasota, Alexander Lazar, Robert G Maki, Markku Miettinen, Amy Noffsinger, Mary Kay Washington, Thomas Krausz.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20121601     DOI： 10.5858/134.2.165

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  21 in total

1.  Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST.

Authors:  Abbas Agaimy; Nikolaos Vassos; Peter H Wunsch; Werner Hohenberger; Arndt Hartmann; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

Review 2.  Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion.

Authors:  Robert G Maki; Jean-Yves Blay; George D Demetri; Jonathan A Fletcher; Heikki Joensuu; Javier Martín-Broto; Toshirou Nishida; Peter Reichardt; Patrick Schöffski; Jonathan C Trent
Journal:  Oncologist       Date:  2015-06-12

Review 3.  Gastrointestinal stromal tumors during pregnancy: a systematic review of an uncommon but treatable malignancy.

Authors:  G Zarkavelis; D Petrakis; N Pavlidis
Journal:  Clin Transl Oncol       Date:  2015-06-09       Impact factor: 3.405

4.  The KDM6A-SPARCL1 axis blocks metastasis and regulates the tumour microenvironment of gastrointestinal stromal tumours by inhibiting the nuclear translocation of p65.

Authors:  Chaoyong Shen; Luyin Han; Baike Liu; Guixiang Zhang; Zhaolun Cai; Xiaonan Yin; Yuan Yin; Zhixin Chen; Bo Zhang
Journal:  Br J Cancer       Date:  2022-02-08       Impact factor: 9.075

5.  Gastrointestinal Stromal Tumors Risk of Recurrence Stratification by Tumor Volume is a Best Predictor Compared with Risk Based on Mitosis and Tumor Size.

Authors:  Leonardo S Lino-Silva; Patricia Segales-Rojas; Eduardo Aguilar-Cruz; Rosa A Salcedo-Hernández; César Zepeda-Najar
Journal:  J Gastrointest Cancer       Date:  2019-09

6.  The Impact of Imatinib on Survival and Treatment Trends for Small Bowel and Colorectal Gastrointestinal Stromal Tumors.

Authors:  Hamda Almaazmi; Miloslawa Stem; Brian D Lo; James P Taylor; Sandy H Fang; Bashar Safar; Jonathan E Efron; Chady Atallah
Journal:  J Gastrointest Surg       Date:  2019-08-06       Impact factor: 3.452

7.  Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.

Authors:  Kjetil Søreide; Oddvar M Sandvik; Jon Arne Søreide; Einar Gudlaugsson; Kjersti Mangseth; Hans Kristian Haugland
Journal:  Clin Transl Oncol       Date:  2012-07-18       Impact factor: 3.405

Review 8.  Clinical and therapeutic considerations of GIST.

Authors:  M Gheorghe; D Predescu; C Iosif; C Ardeleanu; F Băcanu; S Constantinoiu
Journal:  J Med Life       Date:  2014-06-25

9.  Indian Council of Medical Research consensus document for the management of gastrointestinal stromal tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Savio G Barreto; Raju T Chacko; Purvish M Parikh; Jeremy Pautu; Supreeta Arya; Prachi Patil; Srinivas C Chilukuri; B Ganesh; Tanvir Kaur; Deepak Shukla; Goura Shankar Rath
Journal:  Indian J Med Paediatr Oncol       Date:  2014-10

Review 10.  GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).

Authors:  Andrés Poveda; Xavier García del Muro; Jose Antonio López-Guerrero; Virginia Martínez; Ignacio Romero; Claudia Valverde; Ricardo Cubedo; Javier Martín-Broto
Journal:  Cancer Chemother Pharmacol       Date:  2014-09-06       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.